Kevin B Koronowski Selected Research

Infarction (Infarctions)

11/2017

Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin B Koronowski Research Topics

Disease

7	Brain Ischemia (Cerebral Ischemia) 06/2019 - 01/2015
5	Ischemia 01/2018 - 01/2015
2	Stroke (Strokes) 11/2017 - 01/2015
1	Starvation 01/2021
1	Cognitive Dysfunction 01/2020
1	Hyperglycemia 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Wounds and Injuries (Trauma) 10/2018
1	AIDS-Related Complex (ARC) 12/2017
1	Nervous System Diseases (Neurological Disorders) 11/2017
1	Infarction (Infarctions) 11/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2017
1	Brain Injuries (Brain Injury) 08/2015
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Huntington Disease (Huntington's Disease) 01/2015
1	Heart Arrest (Cardiac Arrest) 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2015
4	Protein Kinase C-epsilonIBA 01/2018 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2017
2	Neuroprotective AgentsIBA 06/2019 - 01/2016
2	SirtuinsIBA 10/2018 - 01/2015
2	NAD (NADH)IBA 10/2018 - 01/2015
2	ResveratrolIBA 11/2017 - 08/2015
2	Sirtuin 1IBA 11/2017 - 01/2015
1	Histones (Histone)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Adenosine Triphosphate (ATP)IBA 06/2019
1	Messenger RNA (mRNA)IBA 12/2017
1	AMPA Receptors (AMPA Receptor)IBA 12/2017
1	Oxygen (Dioxygen)IBA 12/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2017

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2015